How MEK1 and MEK2 Cause Intestinal Cancer
Author Information
Author(s): Voisin Laure, Julien Catherine, Duhamel Stéphanie, Gopalbhai Kailesh, Claveau Isabelle, Saba-El-Leil Marc K, Rodrigue-Gervais Ian Gaël, Gaboury Louis, Lamarre Daniel, Basik Mark, Meloche Sylvain
Primary Institution: Institut de Recherche en Immunologie et Cancérologie, Montreal, Quebec, Canada
Hypothesis
The study investigates the role of MEK1 and MEK2 in the transformation of intestinal epithelial cells and their contribution to colorectal cancer.
Conclusion
Both MEK1 and MEK2 can transform intestinal epithelial cells and induce metastatic tumors, with MEK2 being more critical for the proliferation of colorectal cancer cells.
Supporting Evidence
- Activated MEK1 or MEK2 can transform intestinal epithelial cells.
- Tumors formed from these cells often metastasize to the liver and lungs.
- Silencing MEK2 significantly inhibits the proliferation of colon cancer cells.
Takeaway
Scientists found that two proteins, MEK1 and MEK2, can change normal gut cells into cancer cells, and MEK2 is especially important for cancer cell growth.
Methodology
The study involved expressing active forms of MEK1 and MEK2 in intestinal epithelial cells and assessing their effects on cell behavior and tumor formation in mice.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website